Café

© 2026 Longbridge｜Terms of Service Privacy Policy

GNPX

GNPX

3.9500.00%( 0.000 )

LongbridgeAI

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting | GNPX Stock News

StockTitan

May 25, 2026 at 11:01 PM

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting | GNPX Stock News

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting | GNPX Stock News

Login to unlock140characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Genprex

USGNPX

0.00%

ALPS Medical Breakthrough

USSBIO

iShares Biotechnology ETF

USIBB